tiprankstipranks
Advertisement
Advertisement

Acusensus Seeks ASX Quotation for New Employee Incentive Shares

Story Highlights
  • Acusensus is listing 240,164 new ordinary shares on the ASX under code ACE.
  • These employee incentive shares will be freely tradable, modestly boosting free float and liquidity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Acusensus Seeks ASX Quotation for New Employee Incentive Shares

Claim 30% Off TipRanks

Acusensus Ltd ( (AU:ACE) ) has shared an update.

Acusensus Ltd has applied for quotation of 240,164 ordinary fully paid shares on the ASX under its existing ticker ACE. The new securities, issued on 4 March 2026 under an employee incentive scheme, will be quoted and freely transferable, modestly increasing the company’s free float and aligning staff interests with shareholders.

The move reflects Acusensus’s ongoing use of equity-based remuneration to incentivise employees within the constraints of ASX Listing Rules. While the issuance is relatively small, it incrementally broadens the company’s capital base and may support liquidity in trading of ACE shares over time.

The most recent analyst rating on (AU:ACE) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Acusensus Ltd stock, see the AU:ACE Stock Forecast page.

More about Acusensus Ltd

Acusensus Ltd is listed on the Australian Securities Exchange under the code ACE. The company operates in the technology sector, with its ordinary fully paid shares traded on the ASX and subject to standard listing and quotation rules.

Average Trading Volume: 163,629

Technical Sentiment Signal: Buy

Current Market Cap: A$289.8M

Find detailed analytics on ACE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1